Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

A disabled mum says she has been forced to live most of her life in one room for more than a year due to building delays at ...

Multiple sclerosis (MS ... most people have relapsing-remitting MS. Other types include primary progressive MS, secondary progressive MS, and clinically isolated MS. Contact your doctor if ...

According to the MS Society, certain medications like ocrelizumab (Ocrevus) can slow the progression of the disease in primary progressive multiple sclerosis, and syponimod (Mayzent) can help with ...

in primary progressive multiple sclerosis (PPMS). Data from these studies is expected by the end of next year. In December 2023 the FDA put fenebrutinib’s MS programme under partial clinical ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis ... nervous system ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Graham has had a “crash course in MS” after his diagnosis last year, and is willing to do “whatever it takes” to raise funds ...

Columnist Ben Hofmeister, while searching for motivation in a life with multiple sclerosis, feels he just needs to get around to it.

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...